Hisaoka T, Momotani N, Yoshimura H, Ishikawa N, Ito K, Iino S
Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Nihon Naibunpi Gakkai Zasshi. 1993 Oct 20;69(9):997-1002. doi: 10.1507/endocrine1927.69.9_997.
In this paper, we report on a 40-year-old female with subacute thyroiditis (SAT) who showed high levels of TSH-binding inhibitory immunoglobulins (TBII) and thyroid-stimulation blocking antibodies (TSBAb) from the early stage of the disease. Thyrotoxicosis continued for 2 months and it was subsequently followed by severe hypothyroidism. Levothyroxine was then started. At that time, both TBII and TSBAb were still positive, but they disappeared 6 months later and she remained euthyroid thereafter without treatment. When she was in a thyrotoxic phase and had a suppressed TSH level, her 24-hour radioiodine uptake was not suppressed (11%), and thyroid scan showed partial suppression of uptake in the right lobe. These observations indicate that the presence of TSH receptor antibodies (TRAb) may have modified the changes in thyroid state and the course of SAT.
在本文中,我们报告了一名40岁患有亚急性甲状腺炎(SAT)的女性,她从疾病早期就表现出高水平的促甲状腺激素结合抑制性免疫球蛋白(TBII)和甲状腺刺激阻断抗体(TSBAb)。甲状腺毒症持续了2个月,随后出现严重的甲状腺功能减退。随后开始使用左甲状腺素。当时,TBII和TSBAb均仍为阳性,但6个月后消失,此后未经治疗她一直保持甲状腺功能正常。当她处于甲状腺毒症期且促甲状腺激素水平被抑制时,她的24小时放射性碘摄取未被抑制(11%),甲状腺扫描显示右叶摄取部分受抑制。这些观察结果表明,促甲状腺激素受体抗体(TRAb)的存在可能改变了甲状腺状态的变化和亚急性甲状腺炎的病程。